Eli Lilly is looking to position India as a key hub in its global supply chain as sales of its blockbuster weight-loss drug Mounjaro surge in the country.
U.S. pharmaceutical giant Eli Lilly’s weight-loss therapy Mounjaro has become India’s best-selling drug by value in October, surpassing GSK’s antibiotic Augmentin, according to new data from research firm Pharmarack.
17 Feb 2026-14:20
